Li S, Zhang B, Jiang D, et al. Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae [J]. BMC Bioinformatics, 2010,11: S6.
[9]
Zhang A, Sun H, Yang B, et al. Predicting new molecular target for rhein using network pharmacology [J]. BMC Syst Biol, 2012, 6:20.
[10]
Barabasi A L. Scale-free networks: a decade and beyond [J]. Science, 2009, 325: 412.
[11]
Greef J V D. Perspective: all systems go [J]. Nature, 2011, 480: S87.
[12]
Hopkins A L. Network pharmacology: the next paradigm in drug discovery [J]. Nat Chem Biol, 2008,4: 682.
[13]
Li S, Zhang B. Traditional Chinese medicine network pharmacology: theory, methodology and application [J]. Chin J Nat Med, 2013,11(2):110.
HuY J, Scherngell T, Man S N, et al. Is the United States still dominant in the global pharmaceutical innovation network[J]. PLoS ONE, 2013,8(11): e77247.
[17]
林明辉,余鹰.前列腺素代谢与心血管疾病[J].生命科学,2013,25(2):198.
[18]
Cock T A, Houten S M, Auwerx J. Peroxisome proliferator-activated receptor-γ: too much of a good thing causes harm [J]. EMBO Rep, 2004, 5(2):142.
[19]
Li Y, Qi Y, Huang T H, et al. Pomegranate flower: a unique traditional antidiabetic medicine with dual PPAR-alpha/-gamma activator properties [J]. Diabetes Obes Metab, 2008,10 (1): 10.
[20]
Hamblin M, Chang L, Fan Y, et al. PPARs and the cardiovascular system [J]. Antioxid. Redox Signal, 2009,11(6): 1415.
[21]
Khateeb J, Gantman A, Kreitenberg A J, et al. Paraoxonase 1 (PON1) expression in hepatocytes is upregulated by pomegranate polyphenols: a role for PPAR-gamma pathway [J]. Atherosclerosis, 2010,208 (1): 119.
[22]
Cipolletta D, Feuerer M, Li A, et al. PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells [J]. Nature, 2012,486(7404):549.
[23]
Atanasov A G, Wang J N, Gu S P, et al. Honokiol: a non-adipogenic PPARγ agonist from nature [J]. Biochim Biophys Acta, 2013,1830 (10): 4813.
[24]
Atanasov A G, Blunder M, Fakhrudin N, et al. Polyacetylenes from Notopterygium incisum——new selective partial agonists of peroxisome proliferator-activated receptor-gamma [J]. PLoS ONE, 2013,8 (4): e61755.
